Short Description
Middle East & Africa weight loss and obesity management market by product type (dietary supplements and meal replacements), product form (soft gels, tablets, capsule, powders, gummies & jellies, premixes, liquids, and others), nature (conventional and clean labelled). Category (prescribed and over the counter (OTC)), end user (under 18 years, 18 to 35 years, 35 to 50 years, and above 50 years) distribution channel (store based and non-stored based) Industry Trends and Forecast to 2029.

Market Definition:
Obesity impacts the health of an individual in several ways, such as it may increase the risks of chronic diseases declining the life expectancy of individuals. Various diets, devices, and drugs are utilized with the purpose of controlling or reducing weight in obese individuals in these management programs. It is measured by Body Mass Index (BMI). Various methods used for management of weight loss & obesity are drugs, dietary supplements, weight loss surgery, and exercising. As per the World Health Organization (WHO) information, when the Body-Mass-Index is greater than/equal to 25, the person is categorized as overweight and Body Mass Index (BMI) above 30 is classified as obese.
For instance,
In July 2021, according to Cision US Inc., Body Complete Rx (BCRX) launched their TRIM line, its exclusive plant-based, vegan weight management supplements at The Vitamin Shoppe. The supplement offers benefits such as improve energy, nutrition and helps in weight management

Market Segmentation:
Middle East & Africa weight loss and obesity management market is segmented into six notable segments based on product type, product form, nature, category, end user, and distribution channel.
On the basis of product type, the Middle East & Africa weight loss and obesity management market is segmented into dietary supplements and meal replacements. In 2022, dietary supplements segment is expected to dominate the market due to increasing obese population, rising consumer awareness regarding low-calorie food and beverages in developing economies.
On the basis of product form, the Middle East & Africa weight loss and obesity management market is segmented into the soft gels, tablets, capsule, powders, gummies & jellies, premixes, liquids, and others. In 2022, powder segment is expected to dominate the market due to easy to use nature of powder form as compared to other forms of weight loss and obesity management.
On the basis of nature, the Middle East & Africa weight loss and obesity management market is segmented into the conventional and clean labelled. In 2022, conventional segment is expected to dominate the market due to growing demand for organic, naturally grown products.
On the basis of category, the Middle East & Africa weight loss and obesity management market is segmented into prescribed and over the counter (OTC). In 2022, Over the Counter (OTC) segment is expected to dominate the market due to growing popularity of OTCs for weight loss and obesity management.
On the basis of end user, the Middle East & Africa weight loss and obesity management market is segmented into under 18 years, 18 to 35 years, 35 to 50 years, and above 50 years. In 2022, 18 To 35 years segment is expected to dominate the market due to rise in the rate of childhood obesity.
On the basis of distribution channel, the Middle East & Africa weight loss and obesity management market is segmented into the store based and non-stored based. In 2022, non-stored based segment is expected to dominate the market due to emerging COVID-19 pandemic.


Market Players

The key market players for Middle East & Africa weight loss and obesity management market are listed below:

Herbalife International of America, Inc.
ABH Pharma Inc.
Vitaco,
Amway Corp.
Stepan Company
GNC Holdings, LLC
GlaxoSmithKline plc.
Glanbia PLC
Abbott
Shaklee Corporation
Nu Skin Enterprises
Atlantic Multipower UK Ltd.
Nature's Sunshine Products, Inc.
Ajinomoto Co., Inc.
Bionova
DSM
American Health
Omega Protein Corporation
Integrated BioPharma, Inc.
Bio-Tech Pharmacal
The Himalaya Drug Company
Pharmavite, Ricola
BLACKMORES